BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14741269)

  • 1. Peptidyl aldehydes as slow-binding inhibitors of dual-specificity phosphatases.
    Park J; Fu H; Pei D
    Bioorg Med Chem Lett; 2004 Feb; 14(3):685-7. PubMed ID: 14741269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidyl aldehydes as reversible covalent inhibitors of protein tyrosine phosphatases.
    Fu H; Park J; Pei D
    Biochemistry; 2002 Aug; 41(34):10700-9. PubMed ID: 12186556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-isoavenaciolide covalently binds and inhibits VHR, a dual-specificity phosphatase.
    Ueda K; Usui T; Nakayama H; Ueki M; Takio K; Ubukata M; Osada H
    FEBS Lett; 2002 Aug; 525(1-3):48-52. PubMed ID: 12163160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual-specificity protein phosphatases and its evaluation regarding VHR and cdc25B inhibition.
    Sodeoka M; Sampe R; Kojima S; Baba Y; Usui T; Ueda K; Osada H
    J Med Chem; 2001 Sep; 44(20):3216-22. PubMed ID: 11563920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of T cell antigen receptor signaling by VHR-related MKPX (VHX), a new dual specificity phosphatase related to VH1 related (VHR).
    Alonso A; Merlo JJ; Na S; Kholod N; Jaroszewski L; Kharitonenkov A; Williams S; Godzik A; Posada JD; Mustelin T
    J Biol Chem; 2002 Feb; 277(7):5524-8. PubMed ID: 11733513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VHR and PTP1 protein phosphatases exhibit remarkably different active site specificities toward low molecular weight nonpeptidic substrates.
    Chen L; Montserat J; Lawrence DS; Zhang ZY
    Biochemistry; 1996 Jul; 35(29):9349-54. PubMed ID: 8755712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new VHR dual-specificity protein tyrosine phosphatase inhibitor from Dendrobium moniliforme.
    Bae EY; Oh H; Oh WK; Kim MS; Kim BS; Kim BY; Sohn CB; Osada H; Ahn JS
    Planta Med; 2004 Sep; 70(9):869-70. PubMed ID: 15386195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of a dimeric derivative of RK-682 with increased inhibitory activity against VHR, a dual-specificity ERK phosphatase: implications for the molecular mechanism of the inhibition.
    Usui T; Kojima S; Kidokoro S; Ueda K; Osada H; Sodeoka M
    Chem Biol; 2001 Dec; 8(12):1209-20. PubMed ID: 11755399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and characterization of a potent and selective protein tyrosine phosphatase inhibitor, 2.
    Hamaguchi T; Takahashi A; Kagamizono T; Manaka A; Sato M; Osada H
    Bioorg Med Chem Lett; 2000 Dec; 10(23):2657-60. PubMed ID: 11128645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cinnamic aldehyde derived probes for the active site labelling of pathogenesis associated enzymes.
    Pitscheider M; Sieber SA
    Chem Commun (Camb); 2009 Jul; (25):3741-3. PubMed ID: 19557267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent inhibition of protein-tyrosine phosphatase-1B using the phosphotyrosyl mimetic fluoro-O-malonyl tyrosine (FOMT).
    Roller PP; Wu L; Zhang ZY; Burke TR
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2149-50. PubMed ID: 9873503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel benzofuran inhibitors of human mitogen-activated protein kinase phosphatase-1.
    Lazo JS; Nunes R; Skoko JJ; Queiroz de Oliveira PE; Vogt A; Wipf P
    Bioorg Med Chem; 2006 Aug; 14(16):5643-50. PubMed ID: 16698271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptidyl aldehydes as reversible covalent inhibitors of SRC homology 2 domains.
    Park J; Fu H; Pei D
    Biochemistry; 2003 May; 42(17):5159-67. PubMed ID: 12718560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhodanine derivatives as inhibitors of JSP-1.
    Cutshall NS; O'Day C; Prezhdo M
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3374-9. PubMed ID: 15961311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation.
    Rice RL; Rusnak JM; Yokokawa F; Yokokawa S; Messner DJ; Boynton AL; Wipf P; Lazo JS
    Biochemistry; 1997 Dec; 36(50):15965-74. PubMed ID: 9398331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of VHR dual-specificity protein tyrosine phosphatase activity by flavonoids isolated from Scutellaria baicalensis: structure-activity relationships.
    Lee MS; Oh WK; Kim BY; Ahn SC; Kang DO; Sohn CB; Osada H; Ahn JS
    Planta Med; 2002 Dec; 68(12):1063-5. PubMed ID: 12494330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-bromoacetophenone derivatives as neutral protein tyrosine phosphatase inhibitors: structure-Activity relationship.
    Arabaci G; Yi T; Fu H; Porter ME; Beebe KD; Pei D
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3047-50. PubMed ID: 12372498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transition state and rate-limiting step of the reaction catalyzed by the human dual-specificity phosphatase, VHR.
    Zhang ZY; Wu L; Chen L
    Biochemistry; 1995 Dec; 34(49):16088-96. PubMed ID: 8519766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suramin is an active site-directed, reversible, and tight-binding inhibitor of protein-tyrosine phosphatases.
    Zhang YL; Keng YF; Zhao Y; Wu L; Zhang ZY
    J Biol Chem; 1998 May; 273(20):12281-7. PubMed ID: 9575179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional significance of conserved glycine 127 in a human dual-specificity protein tyrosine phosphatase.
    Zeng WY; Wang YH; Zhang YC; Yang WL; Shi YY
    Biochemistry (Mosc); 2003 Jun; 68(6):634-8. PubMed ID: 12943507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.